# A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Study · id `cardio:ct-nct05433584` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05433584](<https://clinicaltrials.gov/study/NCT05433584>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05433584

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 794 participants.

## Technical summary

Registry record NCT05433584. Randomized; no masking; primary purpose treatment. Start 2022-08-01 (actual); primary completion 2025-10-21 (actual). Results posted on 2026-11-12.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 794 participants (enrolled count; ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Started: 2022-08-01 (actual) (ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2025-10-21 (actual) (ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Completion: 2027-11 (anticipated) (ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Results first posted: 2026-11-12 (ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Countries: United States; Argentina; Canada; Germany; Israel; Italy; Mexico; Puerto Rico; Romania; Slovakia; United Kingdom (ClinicalTrials.gov record NCT05433584, source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05433584-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Acronym: SURPASS-EARLY
- Condition: Type 2 Diabetes
- Intervention (Drug): Tirzepatide
- Intervention (Drug): Antihyperglycemic medication
- Lead sponsor: Eli Lilly and Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry intervention name matches this record: Tirzepatide (`cardio:tirzepatide`)
- Registry lists this organization as the lead sponsor: Eli Lilly and Company (`cardio:eli-lilly`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial (`cardio:pubmed-42184419`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b99573e9257379e5bc4b1d3a1213205b2ba61b5a137de65fdf5a66927e13639e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
